scholarly article | Q13442814 |
P50 | author | Hamid Badali | Q40035132 |
Rasoul Mohammadi | Q41440314 | ||
Mojtaba Didehdar | Q57331837 | ||
Tahereh Shokohi | Q58980845 | ||
Mohammad Hossein Afsarian | Q83737014 | ||
P2093 | author name string | Nasrin Amirrajab | |
Nazanin Lotfi | |||
P2860 | cites work | Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans | Q24550731 |
Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000. | Q30453032 | ||
International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobia | Q30453797 | ||
Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria. | Q33830384 | ||
Caspofungin susceptibility testing of isolates from patients with esophageal candidiasis or invasive candidiasis: relationship of MIC to treatment outcome | Q33935389 | ||
Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011. | Q34372192 | ||
Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. | Q34936576 | ||
Epidemiology of candidemia in Qatar, the Middle East: performance of MALDI-TOF MS for the identification of Candida species, species distribution, outcome, and susceptibility pattern. | Q35071660 | ||
Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance | Q35487439 | ||
Multilocus sequence typing of Candida albicans isolates from a burn intensive care unit in Iran | Q35544090 | ||
Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida. | Q35641405 | ||
Determination of antifungal susceptibility patterns among the clinical isolates of Candida species | Q35646997 | ||
Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata | Q35867789 | ||
Multidrug resistance in yeast Candida | Q35983675 | ||
Current treatment strategies for disseminated candidiasis | Q36342385 | ||
In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates. | Q36803960 | ||
Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geogr | Q37036246 | ||
Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007. | Q37374850 | ||
Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance | Q37875198 | ||
Candida glabrata--unique features and challenges in the clinical management of invasive infections | Q38553440 | ||
Antifungal susceptibility testing of Candida isolates from the Candida surveillance study | Q39901515 | ||
Endocarditis due to a co-infection of Candida albicans and Candida tropicalis in a drug abuser. | Q40237015 | ||
High Recovery Rate of Non-albicans Candida Species Isolated From Burn Patients With Candidemia in Iran. | Q40902635 | ||
Molecular Characterization of Highly Susceptible Candida africana from Vulvovaginal Candidiasis. | Q41578149 | ||
Species distribution and antifungal susceptibility of Candida spp. isolated from superficial candidiasis in outpatients in Iran. | Q42222261 | ||
The impact of new epidemiological cutoff values on Candida glabrata resistance rates and concordance between testing methods | Q42222742 | ||
FKS Mutations and Elevated Echinocandin MIC Values among Candida glabrata Isolates from U.S. Population-Based Surveillance | Q42250085 | ||
Clinical significance of azole antifungal drug cross-resistance in Candida glabrata | Q42408609 | ||
Distributions and antifungal susceptibility of Candida species from mucosal sites in HIV positive patients | Q42992243 | ||
In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program | Q44801009 | ||
Candida glabrata fungemia in transplant patients receiving voriconazole after fluconazole | Q46740583 | ||
Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient | Q46971624 | ||
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. | Q47643534 | ||
Susceptibility of Candida species isolated from immunocompromised patients to antifungal agents. | Q51174529 | ||
P433 | issue | 5 | |
P921 | main subject | Candida glabrata | Q139137 |
emerging pathogen | Q108429945 | ||
P304 | page(s) | e36638 | |
P577 | publication date | 2016-04-23 | |
P1433 | published in | Jundishapur journal of microbiology JJM | Q26841997 |
P1476 | title | In Vitro Activities of Six Antifungal Drugs Against Candida glabrata Isolates: An Emerging Pathogen | |
P478 | volume | 9 |
Q51806793 | Antimicrobial Effect of Copper Oxide Nanoparticles on Some Oral Bacteria and Candida Species. |
Q89912171 | In vitro activity of four triazole antifungal drugs against clinically common and uncommon yeast species |
Q92650185 | Microsatellite Typing and Antifungal Susceptibility of Candida glabrata Strains Isolated From Patients With Candida Vaginitis |
Search more.